Insider Transactions in Q1 2021 at Moderna, Inc. (MRNA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,330,000
$133.29 P/Share
|
|
Mar 10
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
Mar 10
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,197,000
$133.24 P/Share
|
|
Mar 10
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$665,000
$133.24 P/Share
|
|
Mar 10
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Mar 09
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$838,200
$127.11 P/Share
|
|
Mar 09
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$165,000
$25.93 P/Share
|
|
Mar 08
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,478
-33.65%
|
$2,109,184
$128.19 P/Share
|
|
Mar 08
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,478
+28.23%
|
$247,170
$15.79 P/Share
|
|
Mar 08
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$645,000
$129.41 P/Share
|
|
Mar 08
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Mar 05
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.72%
|
$1,413,888
$128.05 P/Share
|
|
Mar 04
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$844,800
$128.58 P/Share
|
|
Mar 04
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$165,000
$25.93 P/Share
|
|
Mar 04
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,280,000
$128.58 P/Share
|
|
Mar 03
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
Mar 03
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,305,000
$145.6 P/Share
|
|
Mar 03
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$725,000
$145.6 P/Share
|
|
Mar 03
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Mar 03
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.62%
|
$1,450,000
$145.6 P/Share
|
|
Mar 03
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Mar 02
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,009,800
$153.77 P/Share
|
|
Mar 02
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$165,000
$25.93 P/Share
|
|
Mar 02
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.62%
|
$1,530,000
$153.77 P/Share
|
|
Mar 02
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Mar 01
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$765,000
$153.84 P/Share
|
|
Mar 01
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Mar 01
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-34.58%
|
$1,510,000
$151.99 P/Share
|
|
Mar 01
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+41.67%
|
$130,000
$13.22 P/Share
|
|
Feb 26
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.92%
|
$1,712,130
$155.43 P/Share
|
|
Feb 25
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,500,000
$150.89 P/Share
|
|
Feb 24
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Feb 24
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,350,000
$150.41 P/Share
|
|
Feb 24
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$750,000
$150.41 P/Share
|
|
Feb 24
2021
|
Afeyan Noubar |
SELL
Open market or private sale
|
Indirect |
1,753,697
-1.8%
|
$257,793,459
$147.11 P/Share
|
|
Feb 23
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.07%
|
$2,160,000
$144.09 P/Share
|
|
Feb 23
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Feb 23
2021
|
Afeyan Noubar |
SELL
Open market or private sale
|
Indirect |
2,947,638
-1.14%
|
$424,459,872
$144.01 P/Share
|
|
Feb 22
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-37.61%
|
$820,000
$164.98 P/Share
|
|
Feb 22
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Feb 22
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$830,000
$166.63 P/Share
|
|
Feb 22
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Feb 22
2021
|
Afeyan Noubar |
SELL
Open market or private sale
|
Indirect |
1,836,766
-0.82%
|
$301,229,624
$164.7 P/Share
|
|
Feb 19
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.86%
|
$1,933,050
$175.37 P/Share
|
|
Feb 18
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,710,000
$171.8 P/Share
|
|
Feb 17
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Feb 17
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,566,000
$174.28 P/Share
|
|
Feb 16
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$910,000
$182.8 P/Share
|
|
Feb 16
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Feb 16
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.92%
|
$2,730,000
$182.8 P/Share
|